Reuters logo
BRIEF-Prescient Therapeutics FY loss $2.6 mln
August 29, 2017 / 8:08 AM / 3 months ago

BRIEF-Prescient Therapeutics FY loss $2.6 mln

Aug 29 (Reuters) - Prescient Therapeutics Ltd:

* FY loss for year attributable $2.6 million

* FY revenues from ordinary activities up 1,452.9 pct to $166,220

* FY total revenues $1.2 million versus $1.0 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below